Phase 1 study of HPV16-specific immunotherapy with E6E7 fusion protein and ISCOMATRIX? adjuvant in women with cervical intraepithelial neoplasia
Top Cited Papers
- 25 November 2004
- Vol. 23 (2) , 172-181
- https://doi.org/10.1016/j.vaccine.2004.05.013
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: